Korea's Reimbursement Steps Spark Drug Price Cut Concerns
Executive Summary
In its first announcement of major health care measures since the Moon Jae-in administration took charge, South Korea unveils steps to hike its national health insurance coverage ratio to levels in advanced countries, raising concerns that this might lead to sharp drug price cuts.
You may also be interested in...
Korea To Reform Reimbursement Management To Cut Expenditure
To trim the healthcare financial burden and boost the country’s national health insurance coverage as planned, South Korea will introduce a drug re-evaluation system to adjust prices of both novel and generic drugs, drawing a negative response from the pharma industry.
Korea Lowers Medical Cost For Rare Disease Patients, Eases Off-Label Use Rules
In an ongoing effort to improve access to drugs and provide more treatment options for rare disease patients, South Korea unveils new steps to lower their treatment costs and expand the scope of what are considered rare diseases.
US, Korea FTA Talks To Improve Pro-Innovation Pricing System
The US and South Korea's agreement to modify Korea's drug pricing system for innovative drugs raises concerns over an increased price burden for global drugs in the country.